[HTML][HTML] Context-dependent TGFβ family signalling in cell fate regulation
L Richardson, SG Wilcockson, L Guglielmi… - … Reviews Molecular Cell …, 2023 - nature.com
The transforming growth factor-β (TGFβ) family are a large group of evolutionarily conserved
cytokines whose signalling modulates cell fate decision-making across varying cellular …
cytokines whose signalling modulates cell fate decision-making across varying cellular …
[HTML][HTML] Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
MKK Chan, ELY Chan, ZZ Ji, ASW Chan… - … of Targeted Anti …, 2023 - ncbi.nlm.nih.gov
Transforming growth factor-β (TGF-β) signaling is an important pathway for promoting the
pathogenesis of inflammatory diseases, including cancer. The roles of TGF-β signaling are …
pathogenesis of inflammatory diseases, including cancer. The roles of TGF-β signaling are …
Lactate acidosis and simultaneous recruitment of TGF-β leads to alter plasticity of hypoxic cancer cells in tumor microenvironment
Lactate acidosis is often observed in the tumor microenvironment (TME) of solid tumors. This
is because glucose breaks down quickly via glycolysis, causing lactate acidity. Lactate is …
is because glucose breaks down quickly via glycolysis, causing lactate acidity. Lactate is …
TGF-β signaling in health, disease, and therapeutics
Z Deng, T Fan, C Xiao, H Tian, Y Zheng, C Li… - Signal transduction and …, 2024 - nature.com
Transforming growth factor (TGF)-β is a multifunctional cytokine expressed by almost every
tissue and cell type. The signal transduction of TGF-β can stimulate diverse cellular …
tissue and cell type. The signal transduction of TGF-β can stimulate diverse cellular …
An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis
JW Jackson, FC Streich Jr, A Pal, G Coricor… - Science …, 2024 - science.org
Inhibitors of the transforming growth factor–β (TGF-β) pathway are potentially promising
antifibrotic therapies, but nonselective simultaneous inhibition of all three TGF-β homologs …
antifibrotic therapies, but nonselective simultaneous inhibition of all three TGF-β homologs …
Tumor in the crossfire: inhibiting TGF-β to enhance cancer immunotherapy
NP Tschernia, JL Gulley - BioDrugs, 2022 - Springer
Cancer immunotherapy using monoclonal antibodies targeting immune checkpoints has
undoubtedly revolutionized the cancer treatment landscape in the last decade. Immune …
undoubtedly revolutionized the cancer treatment landscape in the last decade. Immune …
[HTML][HTML] Microvascular significance of TGF-β axis activation in COVID-19
LM Arguinchona, C Zagona-Prizio, ME Joyce… - Frontiers in …, 2023 - frontiersin.org
As 2023 approaches, the COVID-19 pandemic has killed millions. While vaccines have
been a crucial intervention, only a few effective medications exist for prevention and …
been a crucial intervention, only a few effective medications exist for prevention and …
Therapeutic approaches for treating pulmonary arterial hypertension by correcting imbalanced TGF-β superfamily signaling
P Andre, SR Joshi, SD Briscoe, MJ Alexander… - Frontiers in …, 2022 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a rare disease characterized by high blood
pressure in the pulmonary circulation driven by pathological remodeling of distal pulmonary …
pressure in the pulmonary circulation driven by pathological remodeling of distal pulmonary …
First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment
M Burciaga-Flores, AL Márquez-Aguirre, S Dueñas… - Scientific Reports, 2023 - nature.com
Immunotherapies based on antibody fragments have been developed and applied to human
diseases, describing novel antibody formats. The vNAR domains have a potential …
diseases, describing novel antibody formats. The vNAR domains have a potential …
Reciprocal regulation of cancer-associated fibroblasts and tumor microenvironment in gastrointestinal cancer: implications for cancer dormancy
Simple Summary Gastrointestinal (GI) cancers are the leading cancer-related deaths
worldwide. Despite improved survival rates with current treatments, recurrence remains a …
worldwide. Despite improved survival rates with current treatments, recurrence remains a …